This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Which passive funds are cheap for retirement? Focus on low-fee, diversified funds to maximize long-term growth with predictable costs.
23,256 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
New on-chain data shows a growing cohort of XRP whales, with wallets holding 10,000 XRP or more rising to a new high....
Klarna stunned the market on Thursday with a rally following solid quarterly results. This article unpacks the driver...
A new, concentrated fund is delivering outsized tech gains fueled by Nvidia, Micron and TSMC. The fund’s early-2026 s...
Jeff Bezos publicly challenged Elon Musk's plan for space-based data centers, calling the proposed timeline likely to...
Bitcoin jumped toward $77,000 after early reports of a breakthrough in Iran peace talks sparked risk-on trading. Anal...
A surge in Redwire shares mirrors a broader buzz around space stocks. Learn what’s driving the rally, what it means f...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...
Could buying ethereum today spark outsized gains? This article weighs a bank's bold thesis against real-world risks a...
Broadcom is slated to report fiscal Q2 results after the market closes today, with investors focusing on AI-driven re...
With summer on the horizon, energy markets react to travel demand and geopolitics. This guide highlights three energy...
Ripple (XRP) has fallen about 38% in 2026, trading near $1 as Bitcoin and Ethereum drag the market lower. Analysts wa...